Pfizer RSV vaccine wins CDC recommendation for seasonal use only Helen Branswell By Helen Branswell Sept. 22, 2023

https://www.statnews.com/2023/09/22/pfizer-rsv-vaccine-cdc-seasonal-recommendation/?utm_campaign=morning_rounds&utm_medium=email&_hsmi=275436977&_hsenc=p2ANqtz-9mYIMtnydWyBvKQTvyXulE_LExU8sDYh9WkGpKiEJWlGZ8XdNmiHU6fV-5xfRYZdCmJZ8ZNHqlA_g8zgcSdS_CeSxrzg&utm_content=275436977&utm_source=hs_email CDC backs maternal RSV vaccine for seasonal use Pfizer’s new shot to protect infants against RSV by vaccinating their mothers late in pregnancy won a limited recommendation Friday from an expert panel that advises the Centers for Disease Control and Prevention, STAT's Helen Branswell reports. The panel said the vaccine should be given to pregnant women between September and January in order to protect babies born between October and March, when RSV traditionally peaks. “This is another new tool we can use this fall and winter to help protect lives,” CDC Director Mandy Cohen said in a statement. A monoclonal antibody to protect newborns from RSV was also recently approved — but experts told Branswell earlier this year they were worried the U.S. may not put this new arsenal of tools to good use. Read more about Pfizer's new vaccine.